[Pubmed] Botulinum Toxin Procedures: A Practical Approach to Cosmetic Injections

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 6501
Enregistré le : 31 mai 2020 09:57
6
Zodiaque :
Âge : 22
Contact :
    unknown unknown

[Pubmed] Botulinum Toxin Procedures: A Practical Approach to Cosmetic Injections

Message par RSS-Bot »


Am Fam Physician. 2026 May;113:449-456.

ABSTRACT

Botulinum toxin injection for treatment of facial wrinkles is the most commonly performed minimally invasive cosmetic procedure in the United States. Cosmetic indications approved by the US Food and Drug Administration include treatment of wrinkles in the upper face (eg, glabellar lines [frown lines], frontalis lines [horizontal forehead lines], lateral orbicularis oculi lines [crow's feet]). Treatment offers predictable results with high patient satisfaction and few adverse effects. Facial wrinkles are formed by dermal atrophy and repetitive contraction of underlying musculature. Injection of small quantities of botulinum toxin, a potent neurotoxin, into specific overactive muscles causes localized muscle relaxation, smoothing the overlying skin and thereby reducing wrinkles. Clinical effects of botulinum toxin typically take 2 weeks to fully develop and last approximately 3 to 4 months. Treatment of dynamic wrinkles, seen during muscle contraction, yield more dramatic results than static wrinkles, which are visible at rest. Botulinum toxin injection is contraindicated in patients with keloidal scarring, neuromuscular disorders (eg, myasthenia gravis), and allergy to constituents of the botulinum toxin product. Minor bruising and swelling can occur with these injections. Temporary blepharoptosis and eyebrow ptosis are technique-dependent complications, and their incidence declines as injector skill improves. Clinicians can attain procedural proficiency through formal instructional courses and precepting with an experienced aesthetic medicine clinician.

PMID:42202343


Source: https://pubmed.ncbi.nlm.nih.gov/4220234 ... 6&v=2.20.0
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur [email protected]


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »